Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and engaged in early discussions, they said. In February, Novo Holdings, the holding company of Novo Nordisk, acquired US-based publicly-listed contract development and manufacturing organisation Catalent for $16.5 billion.
ETMarkets Smart Talk: Growth vs Value – Sonam Srivastava on navigating the next leg of the market rally
While a soft landing remains a possibility, the market’s performance will depend on how effectively central banks navigate interest rate adjustments and how global economies
September 20, 2024